China’s Anbang Gets $9.7B Capital Injection to Bolster Solvency After Alleged Fraud
China is injecting 60.8 billion yuan ($9.7 billion) into Anbang Insurance Group Co. as it attempts to contain the fallout after the company’s former chairman was accused of masterminding a multi-billion dollar fraud.
The move is aimed at ensuring Anbang’s solvency and protecting policyholders’ interests, the China Insurance Regulatory Commission said Wednesday. The government is trying to revamp and stabilize a company that burst onto the global scene in 2014 with the purchase of New York’s Waldorf Astoria hotel, but was seized by regulators in February.
Anbang’s former Chairman Wu Xiaohui is accused of masterminding a massive fraud, using unauthorized sales of investment-type policies to prop up the acquisitive company’s capital. The case against him is one of the most striking illustrations of China’s war against financial risk; in court last week prosecutors alleged that Wu’s actions had threatened national financial security. By injecting capital, the government is protecting the banks that funded Anbang and the public who invested in its products, said Brock Silvers, managing director at Kaiyuan Capital.
“A bank failure could trigger economy-wide repercussions, while significant losses for a broad class of retail investors could impact the Communist Party’s standing with the general public,” Shanghai-based Silvers said in an email.
The money will come from the China Insurance Security Fund, an industry-funded body that bails out troubled insurers and which had a balance of 116 billion yuan as of January. It plans to hold its stake in Anbang only temporarily, the company said in a statement.
Much of Anbang’s growth was powered by sales of short-term, high-yield products that the company used to fund purchases of long-term assets such as real estate — a duration mismatch that had long worried analysts and regulators.
The charges against Wu alleged wrongdoing going as far back as 2007. He had ordered up fraudulent financial statements and used money raised from fraud for investment, debt repayment and personal use, a Shanghai court said last week.
Wu disputed both the facts and the charges, saying that he didn’t understand the law and didn’t know if his behavior amounts to crime, according to the court. He was later quoted by the court as saying he “realized the crimes and regrets the crimes,” asking for leniency.
Anbang’s registered capital will be kept at 61.9 billion yuan after the injection, the CIRC said, adding that the company will start to select strategic investors and aims to introduce private capital as soon as possible.
China’s government in February seized control of Anbang for at least a year.
Related:
- Ex-Chairman of China’s Anbang ‘Doesn’t Deserve Leniency,’ Say Prosecutors
- Former Chairman of China’s Anbang Pleads for Leniency in $10B Fraud Trial
- Anbang’s Former Chairman Goes on Trial, Accused of Masterminding $10.4B Fraud
- China’s Anbang ‘Committed’ to Overseas Units After Government Takeover
- China Seizes Control of Anbang; Acquisitive Chairman Faces Fraud Prosecution
- Q&A on China’s Takeover of Giant Anbang Insurance
- China Seeks to Broker Sale of a Stake in Anbang Insurance: Sources
- As China’s Insurance Market Liberalizes, There Will Be Many Winners: Opinion
- China’s Move to Curb Overseas Deals Designed to Avoid Japan-Style Bust
- Quick Selldown of Anbang’s Overseas Assets May Prove Difficult
- New York’s Waldorf Owner Pressured to Sell as China Clampdown Escalates
- Chinese Government Asks Anbang Insurance to Sell Overseas Assets: Sources
- Chinese Banks Backing Away from Anbang Insurance
- China’s Anbang Denies Chairman Has Been Prevented from Leaving Country
- China’s Anbang Denies Accusation It Lied About Finances
- FGL Pulls $1.6B Deal with China’s Anbang; Other Suitors Interested
- Anbang Insurance, Kushner End Manhattan Talks as Lawmakers Cite Conflicts